Concepedia

Amir Nikooienejad

AN

5

Publications

830

Citations

5

H-Index

2012

Active since

Affiliations

Eli Lilly (United States)(Current)

Texas A&M University

Amir Nikooienejad is an author at Eli Lilly (United States) specializing in molecular ecology, bioinformatics, and genetics.

Top concepts

Publications per year

2012–2020

5

Publications

5

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes

Mark L. Hartman, Arun J. Sanyal, Rohit Loomba et al. · Diabetes Care · 2020 · 321 citations · Full text

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

Melissa K. Thomas, Amir Nikooienejad, Ross Bray et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 300 citations · Full text

The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

Jonathan M. Wilson, Amir Nikooienejad, Deborah A. Robins et al. · Diabetes Obesity and Metabolism · 2020 · 148 citations · Full text

Bayesian variable selection for binary outcomes in high-dimensional genomic studies using non-local priors

Amir Nikooienejad, Wenyi Wang, Valen E. Johnson · Bioinformatics · 2016 · 39 citations · Full text

Identification and Analysis of the First 2009 Pandemic H1N1 Influenza Virus from U.S. Feral Swine

Alfonso Clavijo, Amir Nikooienejad, Mohammad Shahrokh Esfahani et al. · Zoonoses and Public Health · 2012 · 22 citations · Full text

, , +19

Rows per page

1–5 of 5